--- title: "Shenzhen Neptunus Interlong Bio-Technique Co. (8329) stock" url: "https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. (HKEX: 8329), Hong Kong. The directory classifies it as Pharmaceuticals: Major." --- 8329 Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. HKEX · Hong Kong # Shenzhen Neptunus Interlong Bio-Technique Co. (8329) news Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8329, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Shenzhen Neptunus Interlong Bio-Technique Co. news We have not published a story on Shenzhen Neptunus Interlong Bio-Technique Co. yet. When there is news, it will appear here. ## Shenzhen Neptunus Interlong Bio-Technique Co. at a glance - **Ticker**: 8329 - **Listing**: HKEX - **Country**: Hong Kong ### Related companies - [Regencell Bioscience Holdings](https://aibio.space/companies/regencell-bioscience/) NASDAQ: RGC - [China Traditional Chinese Medicine Holdings Co.](https://aibio.space/companies/china-traditional-chinese-medicine/) HKEX: 570 - [InSilico Medicine Cayman TopCo](https://aibio.space/companies/insilico-medicine-cayman-topco/) HKEX: 3696 - [SSY Group](https://aibio.space/companies/ssy/) HKEX: 2005 - [China Resources Pharmaceutical Group](https://aibio.space/companies/china-resources-pharmaceutical/) HKEX: 3320 - [Sanai Health Industry Group Company](https://aibio.space/companies/sanai-health-industry/) HKEX: 1889 - [China Regenerative Medicine International](https://aibio.space/companies/china-regenerative-medicine-international/) HKEX: 8158 - [Sino Biopharmaceutical](https://aibio.space/companies/sino-biopharmaceutical/) HKEX: 1177 ### Also on HKEX - [TenNor Therapeutics Suzhou](https://aibio.space/companies/tennor-therapeutics-suzhou/) 6872 - [3SBio](https://aibio.space/companies/3sbio/) 1530 - [CF PharmTech](https://aibio.space/companies/cf-pharmtech/) 2652 - [IMPACT Therapeutics](https://aibio.space/companies/impact-therapeutics/) 7630 - [ImmuneOnco Biopharmaceuticals (Shanghai)](https://aibio.space/companies/immuneonco-biopharmaceuticals-shanghai/) 1541 - [China Biotech Services Holdings](https://aibio.space/companies/china-biotech-services/) 8037 ## Questions about Shenzhen Neptunus Interlong Bio-Technique Co. What is the ticker symbol of Shenzhen Neptunus Interlong Bio-Technique Co.? Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. trades under the ticker 8329 on HKEX. Where is Shenzhen Neptunus Interlong Bio-Technique Co. listed? Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. is listed on HKEX. Which country or territory is Shenzhen Neptunus Interlong Bio-Technique Co. listed under? Our directory records Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. under Hong Kong. What does Shenzhen Neptunus Interlong Bio-Technique Co. do? Our directory classifies Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. as: Pharmaceuticals: Major. This is a directory classification, not a description of the pipeline. What is the ISIN of Shenzhen Neptunus Interlong Bio-Technique Co.? The ISIN recorded for Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. is CNE100000775. Does aibio.space cover Shenzhen Neptunus Interlong Bio-Technique Co.? aibio.space lists Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. Which companies are similar to Shenzhen Neptunus Interlong Bio-Technique Co.? Companies in our directory listed in the same country and business area as Shenzhen Neptunus Interlong Bio-Technique Co.: Regencell Bioscience Holdings, China Traditional Chinese Medicine Holdings Co., InSilico Medicine Cayman TopCo, SSY Group, China Resources Pharmaceutical Group, Sanai Health Industry Group Company. ## Investor discussion: Shenzhen Neptunus Interlong Bio-Technique Co. Members talk about Shenzhen Neptunus Interlong Bio-Technique Co. (8329). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Press releases Headlines of Shenzhen Neptunus Interlong Bio-Technique Co.'s own announcements, newest first. Each opens the full release on the newswire that carried it. 1. 2026-09-14 HKEXnews [VOLUNTARY ANNOUNCEMENT - ENTERING INTO OF JOINT VENTURE AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0914/2026091400901.pdf) 2. 2026-08-31 HKEXnews [VOLUNTARY ANNOUNCEMENT - RECEIPT OF REGULATORY DECISION LETTER BY THE CONTROLLING SHAREHOLDER](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0831/2026083100846.pdf) 3. 2026-08-25 HKEXnews [ANNOUNCEMENT OF INTERIM RESULTS FOR THE SIX MONTHS ENDED 30 JUNE 2026](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0825/2026082501351.pdf) 4. 2026-08-12 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0812/2026081200450.pdf) 5. 2026-06-25 HKEXnews [COMPANY INFORMATION SHEET](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0625/2026062501684.pdf) 6. 2026-06-25 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0625/2026062501652.pdf) 7. 2026-06-25 HKEXnews [Articles of Association](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0625/2026062501640.pdf) 8. 2026-06-25 HKEXnews [(1) POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON THURSDAY, 25 JUNE 2026 (2) RE-ELECTION AND APPOINTMENT OF DIRECTORS (3) RE-ELECTION OF THE CHAIRMAN OF THE NEW SESSION OF THE BOARD (4) CHANGE IN COMPOSITION OF THE AUDIT COMMITTEE AND NOMINATION COMMITTEE AND (5) CANCELLATION OF THE SUPERVISORY COMMITTEE, AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RELEVANT RULES OF PROCEDURE](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0625/2026062501602.pdf) 9. 2026-06-18 HKEXnews [SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO THE PROPOSED APPOINTMENT OF INDEPENDENT NON-EXECUTIVE DIRECTOR](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0618/2026061801612.pdf) 10. 2026-06-03 HKEXnews [NOTICE OF ANNUAL GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0603/2026060300950.pdf) 11. 2026-05-29 HKEXnews [(1) PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND CANCELLATION OF THE SUPERVISORY COMMITTEE; AND (2) PROPOSED RE-ELECTION AND APPOINTMENT OF DIRECTORS](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0529/2026052902588.pdf) 12. 2026-03-25 HKEXnews [ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0325/2026032502277.pdf) 13. 2026-03-24 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0324/2026032401164.pdf) 14. 2026-03-20 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT - SUPPLEMENTAL ANNOUNCEMENT IN RELATION TO PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0320/2026032000606.pdf) 15. 2026-03-10 HKEXnews [INSIDE INFORMATION ANNOUNCEMENT - PROFIT WARNING](https://www1.hkexnews.hk/listedco/listconews/gem/2026/0310/2026031000938.pdf) 16. 2025-12-23 HKEXnews [POLL RESULTS OF THE EXTRAORDINARY GENERAL MEETING HELD ON 23 DECEMBER 2025](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1223/2025122300248.pdf) 17. 2025-11-24 HKEXnews [Documents on Display](https://www1.hkexnews.hk/listedco/listconews/gem/dod/en.html) 18. 2025-11-24 HKEXnews [NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1124/2025112400211.pdf) 19. 2025-11-24 HKEXnews [CONTINUING CONNECTED TRANSACTION - RENEWAL OF NEPTUNUS GROUP SALES FRAMEWORK AGREEMENT AND NOTICE OF EXTRAORDINARY GENERAL MEETING](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1124/2025112400201.pdf) 20. 2025-10-30 HKEXnews [CONTINUING CONNECTED TRANSACTION - RENEWAL OF NEPTUNUS GROUP SALES FRAMEWORK AGREEMENT](https://www1.hkexnews.hk/listedco/listconews/gem/2025/1030/2025103000971.pdf) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open HKEX:8329 on TradingView](https://www.tradingview.com/symbols/HKEX-8329/). ## Listing details Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. is a public biotech or pharmaceutical company listed on HKEX under the ticker 8329, recorded under Hong Kong. The directory classifies it as Pharmaceuticals: Major. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Shenzhen Neptunus Interlong Bio-Technique Co. Ltd. - **Ticker**: 8329 - **Listing**: HKEX - **Country or territory**: Hong Kong - **Business scope**: Pharmaceuticals: Major - **ISIN**: CNE100000775 - **Last quote in directory**: 2026-10-22 - **Directory source**: [Listing page](https://www.tradingview.com/symbols/HKEX-8329/) Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Shenzhen Neptunus Interlong Bio-Technique Co. (8329) stock", 2026-10-31, https://aibio.space/companies/shenzhen-neptunus-interlong-bio-technique/